Skip to content

Clinical observation and network pharmacological analysis of modified Simiao Decoction in the treatment of damp-heat intrinsic gout

Clinical observation and network pharmacological analysis of modified Simiao Decoction in the treatment of damp-heat intrinsic gout

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071108
Enrollment
Unknown
Registered
2023-05-05
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

Control Group:Febuxostat was taken orally 20mg/ day for 24 weeks
Test Group:Modified Simiao Decoction 100ml morning and evening 2 times oral
Meanwhile, febuxostat was taken orally 20mg/ day in combination. All took the drug for 24 weeks.

Sponsors

Shanghai Changning Tianshan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria for gout. (2) Those who conform to TCM syndrome differentiation and belong to dampness-heat connotation; (3) Age =18 years and =70 years; There is no gender limitation; (4) Sign informed consent, volunteer for the test, guarantee to take medicine on time and cooperate with the interviewers on schedule. If any of the above is "no", the patient will not be admitted to the trial.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria; (2) Pregnant or lactating women; (3) Patients who are participating in clinical trials of other drugs; (4) Allergic constitution and multiple drug allergy; (5) Patients with serious diseases of other systems (such as cardio-cerebrovascular, liver, kidney, stomach and other primary underlying diseases, mental illness); (6) Patients with secondary gout and calcium pyrophosphate deposition; (7) Used drugs affecting serum uric acid concentration, glucocorticoid drugs, contraceptives, aspirin, salicylate drugs, etc., in the past 1 month; (8) Allergic to the test drug. If any of the above is "yes", the patient will not be admitted to the trial.

Design outcomes

Primary

MeasureTime frame
Incidence of acute attacks of gout;

Secondary

MeasureTime frame
Serum uric acid up to standard rate;

Countries

China

Contacts

Public ContactXiao Zhao

Shanghai Changning Tianshan Traditional Chinese Medicine Hospital

13611786583@163.com+86 13611786583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026